Senior Scientist, Quality Control Biologics (Microbiology) at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
BiopharmaceuticalIndustries

Requirements

  • Experience with Biologics and/or Small Molecules Quality Control microbiology
  • Extensive knowledge of industry best practices and trends in QC microbiology
  • In-depth understanding and application of GMP principles, concepts, practices, and standards in the US and internationally
  • Ability to develop and improve complex concepts, techniques, and standards
  • Ability to develop solutions to complex problems requiring ingenuity, creativity, and innovativeness

Responsibilities

  • Provide support for strategic leadership and oversight of daily microbiological operations
  • Monitor QC test method execution and the microbiological lifecycle management
  • Refine QC procedures across Gilead’s small molecule and biologics manufacturing network, ensuring global cGMP compliance
  • Manage clinical and commercial microbiological sample shipping and testing logistics
  • Perform data entry from CTLs/CMOs into Gilead’s LIMS
  • Contribute to monitoring and refining QC procedures

Skills

Microbiology
Quality Control
Biologics
Small Molecules
cGMP
GMP
LIMS
QC Test Methods
Lifecycle Management
Sample Logistics

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI